Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa

Nephron Clin Pract. 2008;110(3):c158-63. doi: 10.1159/000166607. Epub 2008 Oct 27.

Abstract

Background: Patients with anorexia nervosa (AN) are at a high risk of renal failure. Chronic kidney disease (CKD) is often missed in these patients because the serum creatinine is a poor marker of kidney function. We studied the utility of cystatin C to detect renal failure in this population.

Method: Twenty-seven AN patients were studied. Glomerular filtration rates (GFR) were measured with the chromium-51- ethylenediaminetetraacetate ((51)Cr-EDTA) method. We compared the ability of creatinine and cystatin C to detect stage 3 CKD (GFR below 60 ml/min) by ROC curve analysis.

Results: In this cohort, there is no correlation between GFR and serum creatinine, but there is a significant correlation between cystatin C and GFR. By ROC analysis, the cystatin C concentration is better than the serum creatinine concentration for the detection of stage 3 CKD (area under the curve of 0.86 vs. 0.61, p = 0.05).

Conclusion: Plasma cystatin C is better than serum creatinine in detecting stage 3 CKD in patients with AN.

MeSH terms

  • Adolescent
  • Adult
  • Anorexia Nervosa / blood*
  • Anorexia Nervosa / complications
  • Anorexia Nervosa / diagnosis*
  • Biomarkers / blood
  • Creatinine / blood*
  • Cystatin C / blood*
  • Female
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / diagnosis*
  • Kidney Failure, Chronic / etiology
  • Male
  • Middle Aged
  • Prognosis
  • Reproducibility of Results
  • Risk Assessment / methods
  • Risk Factors
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Biomarkers
  • Cystatin C
  • Creatinine